Peer Review History

Original SubmissionApril 13, 2021
Decision Letter - Xu-jie Zhou, Editor
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

PONE-D-21-12200

Perceptions of risk in pregnancy with chronic disease: a systematic review and thematic synthesis

PLOS ONE

Dear Dr. Ralston,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 31, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Xu-jie Zhou, Ph.D., M.D.,

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.Thank you for stating the following in the Acknowledgments Section of your manuscript:

"Sergio A. Silverio (King’s College London) is currently supported by the National

446 Institute for Health Research Applied Research Collaboration South London [NIHR

447 ARC South London] at King’s College Hospital NHS Foundation Trust. The views

448 expressed are those of the authors and not necessarily those of the NIHR or the

449 Department of Health and Social Care."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The author(s) received no specific funding for this work."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a major revision. The revisions address the comments raised before and improve the manuscript which reports novel findings. The manuscript still needs some attention as follows:

1. Please check the main text (including abstract), especially the references (e.g.: references 26, 37, 40, 47, 48), according to the journal submission guidelines. Article sections are defined as Introduction, Materials and Methods, Results, Discussion, and Conclusions (optional). It should be check according to this order and the journal submission guidelines.

2. Abstract, methods: More detailed information can be given.

3. Methods: Add outcome measurements.

4. Methods, inclusion criteria: Are mixed methods included, excluding quantitative results from these studies? If mixed methods are excluded from the screened articles, check and add them to the method and flow diagram.

5. Line 115: "Quantitative research, systematic reviews, and meta-analyses were excluded". Commentaries, editorials, and case reports/studies were encountered during screened? If available and excluded/included, please check and add to the inclusion criteria section.

6. Table 1: " Ngu, Hay and Menahem (2014), Research design: Qualitative semistructured interview". Isn't it necessary to also add the case studies part to the research design?

7. Study quality, Line 151: "Both reviewers assessed the quality of the studies to be a high standard. " Ngu, Hay and Menahem (2014) article is really high quality?

8. Table 1: Add aims and generally more detailed information can be given and needs rewriting for clarity.

9. Table 1, Pregnancy inclusion criteria: More detailed information can be given and needs.

10. Table 1, Tyer-Viola & Lopez (2014), chronic condition: Please check. If you make changes in the table, add changes in the description of study section.

11. Table 1, first line: Author: -> Author (year) [reference number]

12. Discussions: The articles included in the systematic review were rarely mentioned.

13. Limitations: It should also be added that some studies were conducted with pre-pregnancy women, not with pregnant women.

14. Line 72: [HCP] -> (HCP)

15. Line 98: AND -> and

16. Line 142: Table one -> Table 1

17. Line 169: remove " [HCP] "

Reviewer #2: Women with chronic disease are at increased risk of adverse pregnancy outcomes. Pregnancies which pose higher risk, often require increased medical supervision and intervention. How women perceive their pregnancy risk and its impact on health behavior is poorly understood. In this study, the authors conducted a systematic review to evaluate risk perceptions of pregnancy in women with chronic disease and found that: 1. women’s pregnancy-related behavior and engagement with healthcare services are influenced by their perception of pregnancy risk, 2. Women with chronic disease have risk perceptions which are highly individualized, assessment and communication of women’s pregnancy risk should consider their own understanding and perception of risk. The study design and method are suitable and the data could support the conclusions.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reviewer 1:

1. Please check the main text (including abstract), especially the references (e.g.: references 26, 37, 40, 47, 48), according to the journal submission guidelines. Article sections are defined as Introduction, Materials and Methods, Results, Discussion, and Conclusions (optional). It should be check according to this order and the journal submission guidelines.

Thank you for highlighting the formatting. The references have been corrected and updated. The article sections are now defined as; Introduction, Materials and Methods, Results and Discussion with sub-headings kept to three levels.

2. Abstract, methods: More detailed information can be given.

We have added further detail into the abstract about the quality appraisal, analysis, and the inter-relationship between the themes.

Abstract - Line 31-34 “Quality was assessed using the Critical Appraisal Skills Programme Qualitative checklist and data were synthesised using a thematic synthesis approach. The analysis used all text under the findings or results section from each included paper as data.”

Abstract - Line 41 and 42 “The themes together inter-relate to understand how women with chronic disease perceive their risk in pregnancy.”

Methods - Line 108-113):

“The selection process was guided by the four stages within the PRISMA statement: identification, screening, eligibility and inclusion [21]. Data were initially identified from the search and extracted, with duplicates removed. One author (ER) conducted the extraction and preliminary screening of the titles and abstracts. Two authors (ER & PS) independently screened full texts with the inclusion criteria.”

Line 142-146: please see comment 3 below.

Line 156-157: “The coding and themes were reviewed independently by an author (PS) not involved in the coding process to check for suitability on two randomly selected papers.”

3. Methods: Add outcome measurements.

Thank you for your suggestion. We felt that with qualitative syntheses, outcome measurements – i.e. themes - are not easily defined prior to analysis. However, we recognise that it is important to define the difference between data being analysed and subsequent outcomes – themes in qualitative syntheses. In this review we defined data as being the text under the ‘results’ or ‘findings’ heading of each paper included. We have added this detail in below the sub-heading ‘Data analysis’ (Line 142-146). We are happy to adapt this further according to the editor’s wishes.

Line 142 – 146: “It is important to define in qualitative systematic reviews what constitutes as data. Previous research has defined qualitative data as being the key concepts reported in the findings [24] or as all the text under the results or findings sections. [25]. This analysis adopted the later approach and extracted all the text under the results or findings sections.”

4. Methods, inclusion criteria: Are mixed methods included, excluding quantitative results from these studies? If mixed methods are excluded from the screened articles, check and add them to the method and flow diagram.

Thank you for highlighting this issue, qualitative findings of mixed methods studies were included. This has been clarified in the inclusion criteria: “Qualitative findings within mixed methods studies were included. Quantitative research, systematic reviews, meta-analyses, commentaries, and editorials were excluded.” (Line 128-130)

5. Line 115: "Quantitative research, systematic reviews, and meta-analyses were excluded". Commentaries, editorials, and case reports/studies were encountered during screened? If available and excluded/included, please check and add to the inclusion criteria section.

Thank you for identifying this concern. Commentaries and editorials were excluded from the review, we have added this into the inclusion criteria section (Line 129-130), please see updated quote in point 4 above.

6. Table 1: " Ngu, Hay and Menahem (2014), Research design: Qualitative semistructured interview". Isn't it necessary to also add the case studies part to the research design?

Thank you for your comment. We have now added case studies into the research design in Table 1. Ngu, Hay and Menahem (2014) conducted 20 semi-structured interviews. And there were no other case studies identified in the manuscript reviews.

7. Study quality, Line 151: "Both reviewers assessed the quality of the studies to be a high standard. " Ngu, Hay and Menahem (2014) article is really high quality?

We found the overall quality of the included papers to be of a high standard. In the Ngu, Hay and Menahem (2014) article according to the CASP checklist we found item 4 and 6 difficult to determine and item 8 as not sufficient. In Item 4 (“Was the recruitment strategy appropriate to the aims of the research?”) we found the recruitment strategy was not clearly defined and justified. In item 6 (“Has the relationship between researcher and participants been adequately considered?”), it was not possible to tell whether they had considered the impact of the relationship. We found that other papers also did not adequately address this and therefore, we included this in the Limitation section at line 469-472. Item 8 (“Was the data analysis sufficiently rigorous?”), we thought that further detail was required in the analysis especially as only one researcher conducted the thematic analysis and did not comment on their own bias/influence upon the analysis. We did rate Ngu, Hay and Menahem’s manuscript as the weakest study; however, overall the papers were to a high standard.

8. Table 1: Add aims and generally more detailed information can be given and needs rewriting for clarity.

Thank you for your suggestion. We have added to Table 1 the aims of each paper, along with further information about participants pregnancy status and previous pregnancy experience. We would be happy to receive journal specific guidance to improve the table.

9. Table 1, Pregnancy inclusion criteria: More detailed information can be given and needs.

We have added a separate column with details of the pregnancy status at the time of participation and the previous pregnancy experience of the participants of the individual studies. We hope this has provided more clarity over the pregnancy inclusion criteria.

10. Table 1, Tyer-Viola & Lopez (2014), chronic condition: Please check. If you make changes in the table, add changes in the description of study section.

We have checked the chronic conditions included in Tyer-Viola & Lopez, and included the Lupus/Thyroid disease and cardiac valve repair. This has been added to Table 1 and the description of studies.

11. Table 1, first line: Author: -> Author (year) [reference number]

This has been updated in Table 1.

12. Discussions: The articles included in the systematic review were rarely mentioned.

Thank you for this comment. We have attempted to include references to manuscripts more frequently.

13. Limitations: It should also be added that some studies were conducted with pre-pregnancy women, not with pregnant women.

Thank you for highlighting this. This has been added into the limitations that the studies included different gestations as well as preconception (Line 466).

Line 466: “There was substantial heterogeneity between studies, with diverse overall aims, and inclusion of women at different gestations as well as preconception, with different chronic diseases”

14. Line 72: [HCP] -> (HCP)

Thank you for highlighting this, it has now been corrected.

15. Line 98: AND -> and

Thank you for highlighting this, it has now been corrected.

16. Line 142: Table one -> Table 1

Thank you for highlighting this, it has now been corrected.

17. Line 169: remove " [HCP] "

Thank you for highlighting this, it has now been removed.

Reviewer 2: Women with chronic disease are at increased risk of adverse pregnancy outcomes. Pregnancies which pose higher risk, often require increased medical supervision and intervention. How women perceive their pregnancy risk and its impact on health behavior is poorly understood. In this study, the authors conducted a systematic review to evaluate risk perceptions of pregnancy in women with chronic disease and found that: 1. women’s pregnancy-related behavior and engagement with healthcare services are influenced by their perception of pregnancy risk, 2. Women with chronic disease have risk perceptions which are highly individualized, assessment and communication of women’s pregnancy risk should consider their own understanding and perception of risk. The study design and method are suitable and the data could support the conclusions.

Thank you for your kind comment.

Attachments
Attachment
Submitted filename: Rebuttal.docx
Decision Letter - Xu-jie Zhou, Editor

Perceptions of risk in pregnancy with chronic disease: a systematic review and thematic synthesis

PONE-D-21-12200R1

Dear Dr. Ralston,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Xu-jie Zhou, Ph.D., M.D.,

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Xu-jie Zhou, Editor

PONE-D-21-12200R1

Perceptions of risk in pregnancy with chronic disease: A systematic review and thematic synthesis

Dear Dr. Ralston:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Xu-jie Zhou

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .